Evidence map›Paper›PMID 39677487›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Detection of human brain cancers using genomic and immune cell characterization of cerebrospinal fluid through CSF-BAM.

Alexander H Pearlman, Yuxuan Wang, Anita Kalluri, Megan Parker, Joshua D Cohen, Jonathan Dudley, Jordina Rincon-Torroella, Yuanxuan Xia, Ryan Gensler, Melanie Alfonzo Horwitz and 30 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

40 authors.

Alexander H PearlmanORCID 0000-0002-3504-7517
Yuxuan Wang
Anita Kalluri
Megan Parker
Joshua D Cohen
Jonathan Dudley
Jordina Rincon-Torroella
Yuanxuan Xia
Ryan Gensler
Melanie Alfonzo Horwitz
John Theodore
Lisa Dobbyn
Maria Popoli
Janine Ptak
Natalie Silliman
Kathy Judge
Mari Groves
Christopher M Jackson
George I Jallo
Michael Lim
Mark Luciano
Debraj Mukherjee
Jarushka Naidoo
Sima Rozati
Cole H Sterling
Jon Weingart
Carl Koschmann
Alireza Mansouri
Michael Glantz
David Kamson
Karisa C Schreck
Carlos A Pardo
Matthias Holdhoff
Suman Paul
Kenneth W Kinzler
Nickolas Papadopoulos
Bert Vogelstein
Christopher Douville
Chetan Bettegowda

Funding

ONCOLOGY: CHEMOTHERAPY, IMMUNOLOGY, BIOLOGYT32CA009071 · NCI · JOHNS HOPKINS UNIVERSITY · PI Mary Y Armanios, Nilofer S. Azad · 1985 to 2026
$12.8M
NCI NIH HHS T32 CA009071
6 · The paper itself

Abstract

Patients who have radiographically detectable lesions in their brain or other symptoms compatible with brain tumors pose challenges for diagnosis. The only definitive way to diagnose such patients is through brain biopsy, an obviously invasive and dangerous procedure. Here we present a new workflow termed "CSF-BAM" that simultaneously identifies Statement of significance: There is a paucity of technologies beyond surgical biopsy that can accurately diagnose central nervous system neoplasms. We developed a novel, sensitive and highly specific assay that can detect brain cancers by comprehensively identifying somatic mutations, chromosomal copy number changes, and adaptive immunoreceptor repertoires from samples of cerebrospinal fluid.

Identifiers

PMID39677487
PMCPMC11643193

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.